Transpek Industry Ltd
NSE: TRANSPEK BSE: 506687
Transpek Industry Ltd (TRANSPEK) is a Diversified company listed on NSE: TRANSPEK | BSE: 506687. With a market cap of ₹656 Cr and ROCE of 9.94%, ROE of 7.68%, it operates in the Indian Diversified sector.
₹1,174
52W: ₹864 — ₹1818
PE 11.2 · Book ₹1375 · -15% vs bookMarket Cap₹656 Cr
Stock P/E11.2Price to Earnings
ROCE9.94%Return on Capital
ROE7.68%Return on Equity
Div. Yield1.7%Face Value ₹10
Strengths
- +Company has reduced debt.
- +Company is almost debt free.
- +Stock is trading at 0.83 times its book value
- +Company has been maintaining a healthy dividend payout of 20.6%
Weaknesses
- −The company has delivered a poor sales growth of 2.81% over past five years.
- −Company has a low return on equity of 9.51% over last 3 years.
Shareholding Pattern
Promoters57.47%
FIIs0.02%
DIIs1.6%
Public40.92%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 57.47% | 57.47% | 57.47% | 57.47% | 57.47% | 57.47% | 57.47% | 57.47% |
| FIIs | 0.05% | 0.05% | 0.03%▼0.0 | 0.03% | 0.04%▲0.0 | 0.03%▼0.0 | 0.03% | 0.02%▼0.0 |
| DIIs | 1.79% | 1.86%▲0.1 | 1.86% | 1.86% | 1.83%▼0.0 | 1.64%▼0.2 | 1.64% | 1.6%▼0.0 |
| Public | 40.69% | 40.62%▼0.1 | 40.64%▲0.0 | 40.63%▼0.0 | 40.65%▲0.0 | 40.86%▲0.2 | 40.86% | 40.92%▲0.1 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 121 | 148 | 148 | 152 | 163 | 170 | 165 | 154 | 160 | 158 |
| Expenses | 108 | 121 | 129 | 136 | 140 | 146 | 133 | 130 | 134 | 134 |
| Operating Profit | 13 | 28 | 19 | 16 | 23 | 24 | 32 | 24 | 27 | 25 |
| OPM % | 11% | 19% | 13% | 11% | 14% | 14% | 19% | 16% | 17% | 16% |
| Net Profit | 3 | 14 | 6 | 9 | 10 | 11 | 19 | 16 | 13 | 11 |
| EPS ₹ | 5.35 | 25.21 | 10.1 | 16.63 | 17.1 | 19.07 | 34.46 | 27.89 | 22.63 | 19.42 |
AI Insights
Revenue Trend
TTM revenue at ₹638Cr, down 1.8% YoY. OPM at 17%.
Debt Position
Borrowings at ₹71Cr. Debt-to-equity ratio: 0.09x. Healthy balance sheet.
Capex Cycle
CWIP at ₹13Cr (4% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 1.6% (-0.19pp change). FIIs: 0.02% (-1.83pp change). Promoters hold 57.47%.
Margin & Efficiency
ROCE declining from 16% (Mar 2014) to 10% (Mar 2025). Working capital days: 44.
Valuation
PE 11.2x with 9.94% ROCE. Price is -15% above book value of ₹1,375. Dividend yield: 1.7%.
Recent Announcements
- Board Meeting Intimation for Considering And Approving Audited Financial Results Of The Company For The 31St March, 2026 And To Consider Recommendations Of Dividend, If Any, For The Financial Year 2025-26. 6m - Board meeting on 26 May 2026 to approve Q4 and FY26 audited results, with possible dividend.
- Disclosure Under Regulation 47 Of SEBI LODR Regulations, 2015 20 Apr - Newspaper advertisement issued for special window to transfer and dematerialise physical shares.
- Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 13 Apr - Transpek Industry says it is not a Large Corporate as on 31 March 2026.
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 13 Apr - Company confirms it is not a large corporate; outstanding borrowings were nil as of 31 March 2026.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Submitted Regulation 74(5) confirmation certificate for quarter ended 31 March 2026.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse